These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 6143835

  • 1. [Histamine H2-receptor antagonists as new anti-ulcer agents].
    Takemoto T.
    Nihon Rinsho; 1984 Jan; 42(1):103-13. PubMed ID: 6143835
    [No Abstract] [Full Text] [Related]

  • 2. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
    Hentschel E.
    Wien Med Wochenschr; 1983 Jan; 133(4-5):104-7. PubMed ID: 6134397
    [No Abstract] [Full Text] [Related]

  • 3. [Which drug for peptic ulcer?].
    Hameeteman W, Tytgat GN.
    Ned Tijdschr Geneeskd; 1985 Aug 31; 129(35):1673-6. PubMed ID: 2864643
    [No Abstract] [Full Text] [Related]

  • 4. Histamine H2-receptor antagonists in the short- and long-term treatment of duodenal ulcer.
    Thomas JM, Misiewicz G.
    Clin Gastroenterol; 1984 May 31; 13(2):501-41. PubMed ID: 6146417
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical, secretory, radiological and endoscopic evolution of patients with gastroduodenal ulcer treated with Ulcosilvanil, as compared with those treated with histamine H2 receptor antagonists].
    Contraşiu P, Calinici V.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980 May 31; 32(4):359-63. PubMed ID: 6113650
    [No Abstract] [Full Text] [Related]

  • 6. [Recent developments in drugs antagonistic to factors causing peptic ulcer--clinical effects and problems; histamine H2 receptor blockaders].
    Tani N, Miwa T.
    Nihon Rinsho; 1988 Jan 31; 46(1):12-7. PubMed ID: 2897482
    [No Abstract] [Full Text] [Related]

  • 7. New horizons in the pharmacologic management of peptic ulceration.
    Debas HT, Mulholland MW.
    Am J Surg; 1986 Mar 31; 151(3):422-30. PubMed ID: 2869709
    [Abstract] [Full Text] [Related]

  • 8. Pharmacologic options for the control of peptic ulcer disease.
    Levine JB.
    Adv Intern Med; 1984 Mar 31; 30():425-47. PubMed ID: 6152108
    [No Abstract] [Full Text] [Related]

  • 9. [Acid anti-secretion therapy in gastric and duodenal ulcer].
    Lattanzi A.
    Clin Ter; 1981 Oct 31; 99(2):187-205. PubMed ID: 6119184
    [No Abstract] [Full Text] [Related]

  • 10. Ranitidine: a pilot study in Japan.
    Takemoto T, Okazaki Y, Okita K, Namiki M, Ishikawa M, Oshiba S, Kurokawa K.
    Scand J Gastroenterol Suppl; 1981 Jun 31; 69():125-8. PubMed ID: 6119776
    [Abstract] [Full Text] [Related]

  • 11. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
    Bardhan KD, Naesdal J, Bianchi Porro G, Petrillo M, Lazzaroni M, Hinchliffe RF, Thompson M, Morris P, Daly MJ, Carroll NJ.
    Gut; 1991 Apr 31; 32(4):435-8. PubMed ID: 1673953
    [Abstract] [Full Text] [Related]

  • 12. Another look at peptic ulcer.
    Piper DW, Barr GD.
    Aust Fam Physician; 1981 Aug 31; 10(8):636-40. PubMed ID: 6117272
    [No Abstract] [Full Text] [Related]

  • 13. [Pathogenesis, diagnosis and therapy of ulcer disease. Therapy. 4: Pharmacological basis and therapy with H2 antagonist].
    Med Welt; 1983 Dec 09; 34(49):20, 22. PubMed ID: 6140616
    [No Abstract] [Full Text] [Related]

  • 14. H2-receptor antagonists: development and application.
    Feldman S.
    N Engl Reg Allergy Proc; 1986 Dec 09; 7(4):362-6. PubMed ID: 2886903
    [Abstract] [Full Text] [Related]

  • 15. [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease].
    Simon B, Müller P, Dammann HG.
    Wien Med Wochenschr; 1982 May 31; 132(10):223-8. PubMed ID: 6126962
    [Abstract] [Full Text] [Related]

  • 16. Clinical review of histamine2 receptor antagonists.
    Lipsy RJ, Fennerty B, Fagan TC.
    Arch Intern Med; 1990 Apr 31; 150(4):745-51. PubMed ID: 1970232
    [Abstract] [Full Text] [Related]

  • 17. [Is strong inhibition of gastric acid in the treatment of peptic ulcer sensible?].
    de Bruijne JW, Lamers CB.
    Ned Tijdschr Geneeskd; 1989 Apr 01; 133(13):657-62. PubMed ID: 2566125
    [No Abstract] [Full Text] [Related]

  • 18. Famotidine in the USA: a review of efficacy studies.
    Gitnick G.
    J Int Med Res; 1989 Apr 01; 17 Suppl 1():17A-24A. PubMed ID: 2566539
    [Abstract] [Full Text] [Related]

  • 19. [The place of histamine H2 receptor antagonists in the treatment of diseases of the gastrointestinal tract].
    Visnovský P, Valentík M.
    Cesk Gastroenterol Vyz; 1979 Jul 01; 33(5):312-5. PubMed ID: 41642
    [No Abstract] [Full Text] [Related]

  • 20. [Currents aspects of H2 receptor antagonists in the treatment of ulcers].
    Debongnie JC.
    Acta Gastroenterol Belg; 1992 Jul 01; 55(5-6):415-22. PubMed ID: 1363166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.